PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Riggioni, C.* ; Comberiati, P.* ; Giovannini, M.* ; Agache, I.* ; Akdis, M.* ; Alves-Correia, M.* ; Antó, J.M.* ; Arcolaci, A.* ; Azkur, A.K.* ; Azkur, D.* ; Beken, B.* ; Boccabella, C.* ; Bousquet, J.* ; Breiteneder, H.* ; Carvalho, D.* ; De las Vecillas, L.* ; Diamant, Z.* ; Eguiluz-Gracia, I.* ; Eiwegger, T.* ; Eyerich, S. ; Fokkens, W.* ; Gao, Y.d.* ; Hannachi, F.* ; Johnston, S.L.* ; Jutel, M.* ; Karavelia, A.* ; Klimek, L.* ; Moya, B.* ; Nadeau, K.C.* ; O'Hehir, R.* ; O'Mahony, L.* ; Pfaar, O.* ; Sanak, M.* ; Schwarze, J.* ; Sokolowska, M.* ; Torres, M.J.* ; van de Veen, W.* ; van Zelm, M.C.* ; Wang, D.Y.* ; Zhang, L.* ; Jiménez-Saiz, R.* ; Akdis, C.A.*

A compendium answering 150 questions on COVID-19 and SARS-CoV-2.

Allergy 75, 2503-2541 (2020)
Verlagsversion Postprint DOI PMC
Open Access Green
In December 2019, China reported the first cases of the coronavirus disease 2019 (COVID-19). This disease, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has developed into a pandemic. To date, it has resulted in similar to 9 million confirmed cases and caused almost 500 000 related deaths worldwide. Unequivocally, the COVID-19 pandemic is the gravest health and socioeconomic crisis of our time. In this context, numerous questions have emerged in demand of basic scientific information and evidence-based medical advice on SARS-CoV-2 and COVID-19. Although the majority of the patients show a very mild, self-limiting viral respiratory disease, many clinical manifestations in severe patients are unique to COVID-19, such as severe lymphopenia and eosinopenia, extensive pneumonia, a "cytokine storm" leading to acute respiratory distress syndrome, endothelitis, thromboembolic complications, and multiorgan failure. The epidemiologic features of COVID-19 are distinctive and have changed throughout the pandemic. Vaccine and drug development studies and clinical trials are rapidly growing at an unprecedented speed. However, basic and clinical research on COVID-19-related topics should be based on more coordinated high-quality studies. This paper answers pressing questions, formulated by young clinicians and scientists, on SARS-CoV-2, COVID-19, and allergy, focusing on the following topics: virology, immunology, diagnosis, management of patients with allergic disease and asthma, treatment, clinical trials, drug discovery, vaccine development, and epidemiology. A total of 150 questions were answered by experts in the field providing a comprehensive and practical overview of COVID-19 and allergic disease.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
8.706
2.339
51
57
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Allergy ; Coronavirus Disease 2019 ; Covid-19 ; Sars-cov-2 ; Severe Acute Respiratory Syndrome-related Coronavirus 2; Acute Respiratory Syndrome; Angiotensin-converting Enzyme; Kawasaki-like Disease; Sars-coronavirus; Longitudinal Profile; Spike Glycoprotein; Immune-responses; Epidemic; Asthma; Azithromycin
Sprache englisch
Veröffentlichungsjahr 2020
HGF-Berichtsjahr 2020
ISSN (print) / ISBN 0105-4538
e-ISSN 1398-9995
Zeitschrift Allergy
Quellenangaben Band: 75, Heft: 10, Seiten: 2503-2541 Artikelnummer: , Supplement: ,
Verlag Wiley
Verlagsort 111 River St, Hoboken 07030-5774, Nj Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Allergy Research (IAF)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Allergy
PSP-Element(e) G-505490-001
DOI 10.1111/all.14449
WOS ID WOS:000550399700001
Scopus ID 85088247928
PubMed ID 32535955
Erfassungsdatum 2020-10-05
[➜Korrektur melden]